METABolic Deterioration in HTX Determines Outcomes

Recruiting now

Conditions studied: Heart Transplantation

In brief

METAB-HTX is a prospective, longitudinal cohort study evaluating cardiac and systemic metabolism in heart transplant recipients.

Key facts

Study ID

NCT07372820

Run by

Heinrich-Heine University, Duesseldorf

People needed

270

Starts

2025-07-24

Expected to finish

2032-02-01

Last updated by the study team

2026-01-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age: ≥ 18 years
• Planned or already conducted heart transplantation
• Informed consent

You may not qualify if…

• Absence of informed consent

Where it is running

• University-Hospital Düsseldorf Division of Cardiology, Pneumology and Angiology — Düsseldorf, North Rhine-Westphalia, Germany (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.